Alveolar echinococcosis: from a deadly disease to a well-controlled infection. Relative survival and economic analysis in Switzerland over the last 35 years.
about
The global burden of alveolar echinococcosisAge, season and spatio-temporal factors affecting the prevalence of Echinococcus multilocularis and Taenia taeniaeformis in Arvicola terrestrisWorld Health Organization Estimates of the Global and Regional Disease Burden of 11 Foodborne Parasitic Diseases, 2010: A Data SynthesisEchinococcus metacestode: in search of viability markersCurrent status of diagnosis and treatment of hepatic echinococcosisEnvironmental changes impacting Echinococcus transmission: research to support predictive surveillance and control.Late biliary complications in human alveolar echinococcosis are associated with high mortality.Dynamics of the force of infection: insights from Echinococcus multilocularis infection in foxes.Outcome after Discontinuing Long-Term Benzimidazole Treatment in 11 Patients with Non-resectable Alveolar Echinococcosis with Negative FDG-PET/CT and Anti-EmII/3-10 Serology.Endoscopic Treatment of Biliary Stenosis in Patients with Alveolar Echinococcosis--Report of 7 Consecutive Patients with Serial ERC ApproachThe Burden of Zoonoses in Kyrgyzstan: A Systematic Review.Pitfalls in diagnosis and treatment of alveolar echinococcosis: a sentinel case seriesMetastatic and prognostic factors in patients with alveolar echinococcosis.Epidemiological analysis of the distribution of cystic and alveolar echinococcosis in Osh Oblast in the Kyrgyz Republic, 2000-2013.30-yr course and favorable outcome of alveolar echinococcosis despite multiple metastatic organ involvement in a non-immune suppressed patientFirst identification of Echinococcus multilocularis in rodent intermediate hosts in SwedenHuman alveolar echinococcosis in Kyrgyzstan.A case of Budd-Chiari syndrome associated with alveolar echinococcosisProgressive alveolar echinococcosis after discontinuation of anthelmintic therapy.Support for targeted sampling of red fox (Vulpes vulpes) feces in Sweden: a method to improve the probability of finding Echinococcus multilocularis.Hepatic echinococcosis: clinical and therapeutic aspects.Transmission ecology of taeniid larval cestodes in rodents in Sweden, a low endemic area for Echinococcus multilocularis.A European survey of perendoscopic treatment of biliary complications in patients with alveolar echinococcosis.Inoperable cerebral alveolar echinococcosis controlled with high dosages of albendazole adjusted with monitoring of blood levels.Time course of the antibody response in humans compared with rats experimentally infected with hepatic alveolar echinococcosis.Public Health Follow-up of Suspected Exposure to Echinococcus multilocularis in Southwestern Ontario.Disseminated alveolar echinococcosis resembling metastatic malignancy: a case report.Detection of Echinococcus multilocularis and other foodborne parasites in fox, cat and dog faeces collected in kitchen gardens in a highly endemic area for alveolar echinococcosis.Cyclist: slightly foxed.How to not miss alveolar echinococcosis in hepatic lesions suspicious for cholangiocellular carcinoma.Outcomes After Liver Resection for Hepatic Alveolar Echinococcosis: A Single-Center Cohort Study.Clinical presentation, diagnosis, therapy and outcome of alveolar echinococcosis in dogs.Primary extrahepatic alveolar echinococcosis of the lumbar spine and the psoas muscle.In vitro efficacy of triclabendazole and clorsulon against the larval stage of Echinococcus multilocularis.Galα1-4Galβ1-3GalNAc is the dominant epitope of Em2 antigen, the mucin-type glycoprotein from Echinococcus multilocularis.Establishment of a European-type strain of Echinococcus multilocularis in Canadian wildlife.Should possible recurrence of disease contraindicate liver transplantation in patients with end-stage alveolar echinococcosis? A 20-year follow-up study.Emerging alveolar echinococcosis (AE) in humans and high prevalence of Echinococcus multilocularis in foxes and raccoon dogs in Lithuania.Benzimidazoles for the treatment of cystic and alveolar echinococcosis: what is the consensus?Survival in 76 cats with epilepsy of unknown cause: a retrospective study.
P2860
Q21092287-00EE90DE-58EA-4969-B877-B863D42928D7Q21198911-7DA39FF7-8891-4D0C-A124-432AEE7F0243Q26774963-C1A68623-EDDA-4EC5-8C82-58A83B48384EQ26851691-61F15986-A39E-4BAA-BDE2-54B7328CE018Q28080010-A5BFC827-B147-4B47-A901-9CEB46730539Q30601425-0039EAB1-5DA3-4998-BEFF-0414CB9D9F65Q33626869-8D73ECAC-B294-479B-A0B2-1296A69B4BC6Q35126544-B45ACFE3-8FEE-499A-BBD1-06A6051BAFE8Q35781785-8658ECD6-04ED-4F34-B45D-ACA7596F28E9Q35934247-14FB26F1-89DB-498A-B667-9E716212EEC6Q36069965-D56EDF8C-0C6F-4CF2-A022-C1D0B2B9073DQ36140443-2FC8960C-3535-42E7-9182-2451A907BBA3Q36261700-0AAFA64F-4A3C-410F-9DD2-0564F3491E80Q36429275-B782AFDF-E90B-4177-9BF4-FFEAA55CBC8EQ36588764-66053B78-F16E-470B-AA8B-C86583C1A16CQ36719876-F179D66D-52A1-49C8-8E63-AA0AC9C73661Q37021069-9344F727-4324-4544-AC38-AA99E9101A07Q37165146-5DA20718-2C4B-4E76-8BB9-0796D2175328Q37362166-7F3B08D1-B4D6-4432-8A30-5D1C065F6AD7Q37456730-376E4522-8497-4CA7-BF3F-2F54C2228ECBQ38003142-8B17C2CC-7206-4ABE-8627-BD079C359EDFQ38748657-628C065C-20F5-4B7E-A868-09980FFF130FQ38872291-E107026C-0071-4A48-921B-D3669C35FF82Q39487707-587D432C-B676-476A-9E4C-C4D854F64333Q39523073-645A9960-F202-459C-A991-0C873C2742B9Q39534633-5C5E3631-A5E7-481A-9052-DCCA621AB13DQ40060784-CF2A4828-AA83-4B4A-AA6F-1F74A1584CDAQ40117624-B2E0A3CD-96A3-4209-AA4B-6FAC978BB2B2Q40441344-0C6A9578-ABF4-4BB5-A631-1B4FEB5EAF9EQ40795088-DD1C6C07-099E-4066-8A1B-48EFA462B4B8Q40843185-FE559D43-842D-4519-9B3C-5E5EADC65727Q40922478-63FE0C77-2733-4364-A6C4-C771A4162711Q42052521-7F6AC0E7-5F13-493D-BEF5-8E4E00EAB1F4Q42272747-C8654D26-6A8A-43B8-B264-17B2F0804528Q42719592-4C1D6248-FD2A-451C-B1DF-CC2C736031CEQ44104750-BA68A4EE-E9B9-4546-869E-72B060CB0AAFQ45193310-C7FD5617-B09B-4C29-988E-D5300D45E399Q45758697-BCE24EFB-4AE2-43CD-AA4C-A07CBD939DD4Q46103428-6179CCD5-B5DF-4BC3-AE18-9F603C0EBBECQ47132337-BA5553F5-7089-4B1F-AFDC-7EF7B4A872D8
P2860
Alveolar echinococcosis: from a deadly disease to a well-controlled infection. Relative survival and economic analysis in Switzerland over the last 35 years.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh-hant
name
Alveolar echinococcosis: from ...... erland over the last 35 years.
@en
Alveolar echinococcosis: from ...... erland over the last 35 years.
@nl
type
label
Alveolar echinococcosis: from ...... erland over the last 35 years.
@en
Alveolar echinococcosis: from ...... erland over the last 35 years.
@nl
prefLabel
Alveolar echinococcosis: from ...... erland over the last 35 years.
@en
Alveolar echinococcosis: from ...... erland over the last 35 years.
@nl
P2093
P1476
Alveolar echinococcosis: from ...... erland over the last 35 years.
@en
P2093
Alexander Schweiger
Beat Müllhaupt
Jürg Reichen
Maja Pohar
Nerman Halkik
Philip E Tarr
Rudolf W Ammann
P356
10.1016/J.JHEP.2008.03.023
P577
2008-04-28T00:00:00Z